<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-86626</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Reactivation of hepatitis B in a patient with spondyloarthritis after the suspension of methotrexate and efficacy of treatment with antivirals in association to adalimumab</dc:title>
<dc:description xml:lang="en">We report the case of a male chronic hepatitis B virus (HBV) carrier with HLA-B27 spondyloarthrititis who developed fulminant hepatitis after discontinuation of methotrexate (MTX). Full recovery after therapy with lamivudine and adefovir allowed treatment with adalimumab which was well tolerated. Reactivation of hepatitis B after MTX withdrawal is a very rare complication, which can also occur in association with anti-TNF agents. In patients with positive serology for HBV prophylactic antiviral therapy is recommended(AU)</dc:description>
<dc:creator>Medrano, Marta</dc:creator>
<dc:creator>Cobeta García, Juan Carlos</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Comunicamos el caso de un varón portador crónico de virus de hepatitis B (VHB) con espondiloartritis B27 positivo que desarrolló una hepatitis fulminante tras la suspensión del tratamiento con metotrexato (MTX). Una total recuperación tras terapia con lamivudina y adefovir permitió un tratamiento con adalimumab sin otras complicaciones y buena tolerancia. La reactivación de hepatitis B tras suspensión de MTX es una complicación muy poco frecuente, que también puede ocurrir con los anti-TNF. En pacientes con serología positiva de VHB se recomienda tratamiento profiláctico con antivirales(AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);7(3): 200-202, may.-jun.2011. tab</dc:source>
<dc:identifier>ibc-86626</dc:identifier>
<dc:title xml:lang="es">Reactivación de hepatitis B en un paciente con espondiloartritis tras suspender metotrexato y eficacia del tratamiento con antivirales en asociación con adalimumab</dc:title>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d36004^s22016</dc:subject>
<dc:subject>^d^s22073</dc:subject>
<dc:subject>^d36004^s22036</dc:subject>
<dc:subject>^d36004^s22012</dc:subject>
<dc:subject>^d7435</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6664^s22012</dc:subject>
<dc:subject>^d38623^s22012</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d6657^s22012</dc:subject>
<dc:subject>^d6664^s22016</dc:subject>
<dc:subject>^d38737^s22073</dc:subject>
<dc:subject>^d28169^s22073</dc:subject>
<dc:subject>^d36004^s22032</dc:subject>
<dc:subject>^d13195</dc:subject>
<dc:type>article</dc:type>
<dc:date>201106</dc:date>
</metadata>
</record>
</ibecs-document>
